These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17210164)

  • 61. Practical points in urinary proteomics.
    Thongboonkerd V
    J Proteome Res; 2007 Oct; 6(10):3881-90. PubMed ID: 17824635
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Introducing the CPL/MUW proteome database: interpretation of human liver and liver cancer proteome profiles by referring to isolated primary cells.
    Wimmer H; Gundacker NC; Griss J; Haudek VJ; Stättner S; Mohr T; Zwickl H; Paulitschke V; Baron DM; Trittner W; Kubicek M; Bayer E; Slany A; Gerner C
    Electrophoresis; 2009 Jun; 30(12):2076-89. PubMed ID: 19582709
    [TBL] [Abstract][Full Text] [Related]  

  • 63. What does it need to be a biomarker? Relationships between resolution, differential quantification and statistical validation of protein surrogate biomarkers.
    Schrattenholz A; Groebe K
    Electrophoresis; 2007 Jun; 28(12):1970-9. PubMed ID: 17516580
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Clinical toxicology and metabonomics].
    Horii I
    Chudoku Kenkyu; 2006 Oct; 19(4):373-81. PubMed ID: 17133979
    [No Abstract]   [Full Text] [Related]  

  • 65. Biomarkers of cardiovascular disease: molecular basis and practical considerations.
    Vasan RS
    Circulation; 2006 May; 113(19):2335-62. PubMed ID: 16702488
    [No Abstract]   [Full Text] [Related]  

  • 66. Proteomic characterization of skin and epidermis in response to environmental agents.
    Huang CM; Xu H; Wang CC; Elmets CA
    Expert Rev Proteomics; 2005 Oct; 2(5):809-20. PubMed ID: 16209658
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evolution of clinical proteomics and its role in medicine.
    Boja E; Hiltke T; Rivers R; Kinsinger C; Rahbar A; Mesri M; Rodriguez H
    J Proteome Res; 2011 Jan; 10(1):66-84. PubMed ID: 20715861
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Unraveling the complex proteome for biomarker discovery in gastrointestinal and liver diseases.
    Song K; Hanash S
    Gastroenterology; 2006 Nov; 131(5):1375-8. PubMed ID: 17064703
    [No Abstract]   [Full Text] [Related]  

  • 69. The role of proteomics in toxicology: identification of biomarkers of toxicity by protein expression analysis.
    Kennedy S
    Biomarkers; 2002; 7(4):269-90. PubMed ID: 12171755
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Current topics and problems in toxicology laboratories--8: paradigm shift in clinical toxicological analysis].
    Chudoku Kenkyu; 2010 Sep; 23(3):256-9. PubMed ID: 20865914
    [No Abstract]   [Full Text] [Related]  

  • 71. The added value of proteomics for toxicological studies.
    Miller I; Serchi T; Murk AJ; Gutleb AC
    J Toxicol Environ Health B Crit Rev; 2014; 17(4):225-46. PubMed ID: 24828453
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Clinical intoxication and proteomics].
    Yoshida T
    Chudoku Kenkyu; 2006 Oct; 19(4):365-71. PubMed ID: 17133978
    [No Abstract]   [Full Text] [Related]  

  • 73. Proteome profiling for the identification of lung cancer signatures.
    Cho WC
    Expert Rev Proteomics; 2011 Dec; 8(6):689-92. PubMed ID: 22087654
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Use of proteomics to detect sex-related differences in effects of toxicants: implications for using proteomics in toxicology.
    Rietjens IMCM; Vervoort J; Maslowska-Górnicz A; Van den Brink N; Beekmann K
    Crit Rev Toxicol; 2018 Sep; 48(8):666-681. PubMed ID: 30257127
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Proteomics in mechanistic toxicology: history, concepts, achievements, caveats, and potential.
    Rabilloud T; Lescuyer P
    Proteomics; 2015 Mar; 15(5-6):1051-74. PubMed ID: 25164579
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Some achievements of the Russian Program "molecular and cell biology" in 2003].
    Georggiev GP
    Genetika; 2005 May; 41(5):705-15. PubMed ID: 15977825
    [No Abstract]   [Full Text] [Related]  

  • 77. [Studies on establishment of rapid and sensitive toxicologic biomarkers in risk assessment].
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2000; (118):159-77. PubMed ID: 11534122
    [No Abstract]   [Full Text] [Related]  

  • 78. [Possibilities and limitations in clinical toxicology analysis].
    König H
    Z Med Lab Diagn; 1983; 24(5):suppl 3-12. PubMed ID: 6636948
    [No Abstract]   [Full Text] [Related]  

  • 79. [What poisoning analysis tells us: expected roles in diagnosis and treatment, and strategy for poisoning analysis].
    Hori Y; Iseki T; Yshiki M
    Chudoku Kenkyu; 2005 Jul; 18(3):269-73. PubMed ID: 16119825
    [No Abstract]   [Full Text] [Related]  

  • 80. Organisation of clinical toxicological centres.
    Proudfoot AT
    Acta Pharmacol Toxicol (Copenh); 1977; 41 Suppl 2():65-6. PubMed ID: 302627
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.